SCHEMBL1069501

SCHEMBL1069501

O=C1C(=O)N(C2CCCCCCC2)CCCCC1CO

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 3/20 0.40
GAA P10253 2/20 0.35
POLB P06746 2/20 0.35
ALDH1A1 P00352 2/20 0.35
HPGD P15428 1/20 0.35
HSD17B10 Q99714 1/20 0.35
TYMP P19971 2/20 0.34
PARP1 P09874 1/20 0.34
HTT P42858 1/20 0.34
ESR2 Q92731 1/20 0.34
LMNA P02545 1/20 0.34
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
MAOB P27338 1/20 0.33
ADORA1 P30542 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17704768 0.71 POLB (0.42) HSD11B1GAAPOLBPARP1HTT
SCHEMBL12389317 0.69 ALDH1A1 (0.42) HSD11B1GAAPOLBALDH1A1KMT2A
SCHEMBL4732407 0.69 NOS3 (0.39) HSD11B1GAAPOLBALDH1A1HPGD
SCHEMBL28358583 0.69 HSD11B1 (0.49) HSD11B1ALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL9734889 0.68 POLB (0.46) HSD11B1GAAPOLBALDH1A1PARP1
SCHEMBL8659553 0.67 NOS3 (0.41) HSD11B1GAAPOLBPARP1HTT
SCHEMBL9091338 0.67 HSD11B1 (0.43) HSD11B1GAAPOLBALDH1A1TYMP
SCHEMBL9680501 0.66 CDA (0.37) GAAPOLBALDH1A1HPGDHSD17B10
SCHEMBL9243589 0.65 GRM5 (0.40) HSD11B1GAAPOLB
SCHEMBL867932 0.65 NOS3 (0.42) GAAPOLBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 130 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1613302-B1 PRESERVED AND STABLE COMPOSITIONS CONTAINING PEPTIDE COPPER COMPLEXES AND METHODS RELATED THERETO PROCYTE CORP (US) 2009-12-23 EP claimed
US-7128923-B2 Preserved and stable compositions containing peptide copper complexes and method related thereto PROCYTE CORPORATION (US) 2006-10-31 US claimed
US-12527733-B2 Fragrance compositions ELC MANAGEMENT LLC (US) 2026-01-20 US disclosed
WO-2025019374-A2 DENSIFIED LIGNOCELLULOSIC FIBERS, CONCRETE REINFORCED WITH SUCH FIBERS, AND METHODS FOR FABRICATION AND USE OF SUCH FIBERS INVENTWOOD INC. (US) 2025-01-23 WO disclosed
WO-2024220910-A1 PLANT MATERIALS WITH IMPROVED WATER STABILITY, AND METHODS FOR FABRICATION THEREOF INVENTWOOD INC. (US) 2024-10-24 WO disclosed
EP-4384137-A1 FRAGRANCE COMPOSITIONS ELC Management LLC (US) 2024-06-19 EP disclosed
EP-2658492-B1 AN APERTURED HYDROGEL 3M INNOVATIVE PROPERTIES COMPANY (US) 2023-11-22 EP disclosed
EP-3141239-B1 FRAGRANCE COMPOSITIONS AND USES THEREOF PROCTER & GAMBLE (US) 2023-05-10 EP disclosed
US-20230048533-A1 FRAGRANCE COMPOSITIONS ELC MANAGEMENT LLC 2023-02-16 US disclosed
WO-2023018673-A1 FRAGRANCE COMPOSITIONS ELC MANAGEMENT LLC (US) 2023-02-16 WO disclosed
US-11464716-B1 Semi-permanent colorant composition for hair AMERICAN SPRAYTECH, L.L.C. (US) 2022-10-11 US disclosed
EP-1408912-A2 TEMPERATURE INSENSITIVE ONE-PHASE MICROEMULSIONS Dow Corning Corporation (US) 2004-04-21 EP disclosed
WO-2003101412-A2 SUBSTITUTED HYDROCARBYL FUNCTIONAL SILOXANES FOR HOUSEHOLD, HEALTH, AND PERSONAL CARE APPLICATIONS DOW CORNING CORPORATION (US) 2003-12-11 WO disclosed
US-20030228333-A1 Substituted hydrocarbyl functional siloxanes for household, health, and personal care applications DOW CORNING CORPORATION 2003-12-11 US disclosed
US-20030082129-A1 Hair and skin care compositions containing siloxane-based polyamide copolymers DOW CORNING CORPORATION 2003-05-01 US disclosed
WO-2003009819-A2 TEMPERATURE INSENSITIVE ONE-PHASE MICROEMULSIONS DOW CORNING CORPORATION (US) 2003-02-06 WO disclosed
US-6498197-B1 Temperature insensitive one-phase microemulsions DOW CORNING CORPORATION 2002-12-24 US disclosed
EP-1256336-A2 Two-phase gel composition Penreco (US) 2002-11-13 EP disclosed
US-20020055562-A1 Gel compositions WILMINGTON TRUST, NATIONAL ASSOCIATION 2002-05-09 US disclosed
WO-1998048768-A9 COMPOSITIONS FOR COSMETIC APPLICATIONS MEDLOGIC GLOBAL CORP (US) 1999-03-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030082129-A1 Hair and skin care compositions containing siloxane-based polyamide copolymers CUTA, POLR1C, KRT18 HSD11B1 3729/4885GAA 3790/4885POLB 181/4885
US-12527733-B2 Fragrance compositions CUTA, IL36G, TAS2R40 HSD11B1 3080/4885GAA 1452/4885POLB 1531/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.